Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer

Overview of attention for article published in Frontiers in oncology, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 8 news outlets
twitter: 3 X users

patent: 2 patents

Readers on

mendeley: 247 Mendeley

Summary News X Patents

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,487 followers.

第二世代の抗アンドロゲン：去勢抵抗性前立腺癌の発見から標準治療まで https://t.co/WziOsZCMmL

02 Sep 2019

Reply Repost Favourite

New research: Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer: Prostate cancer is the most commonly diagnosed cancer affecting men in the United States. The prostate is a… https://t.co/QP15upzrOF

02 Sep 2019

Reply Repost Favourite

Great work, Meghan!

28 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.